← Scroll for more →
Financial Statements — XLAB
Balance Sheet
(in millions USD)| Metric | Q4 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | 2.69 | -- | -- |
| Accounts Receivable | 1.15 | -- | -- |
| Total Current Assets | 6.52 | -- | -- |
| Property, Plant & Equipment | 0.01 | -- | -- |
| Total Non-current Assets | 0.20 | -- | -- |
| Total Assets | 6.73 | -- | -- |
| Accounts Payable | 0.92 | -- | -- |
| Total Current Liabilities | 31.89 | 0.01 | 0.00 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 31.89 | 0.01 | 0.00 |
| Retained Earnings | (25.38) | (0.01) | -0.00 |
| Total Stockholder Equity | (25.16) | (0.01) | -0.00 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in thousands USD) (except per-share rows)| Metric | Q1 2026 |
|---|---|
| Total Operating Expenses | 10.00 |
| Operating Income | (10.00) |
| Pretax Income | (10.00) |
| Net Income | (10.00) |
| Basic EPS | (100.00) |
| Diluted EPS | (100.00) |
← Scroll for more columns →